Related Experiment Video
Updated: Jun 10, 2026

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
Trypanocidal activity of aziridinyl nitrobenzamide prodrugs
Chris Bot1, Belinda S Hall, Noosheen Bashir
1Queen Mary Pre-Clinical Drug Discovery Group, School of Biological and Chemical Sciences, Queen Mary University of London, London E1 4NS, United Kingdom.
Abstract:
The trypanocidal agents nifurtimox and benznidazole both function as prodrugs and must undergo enzyme-mediated activation, a reaction catalyzed by type I nitroreductase (NTR). In the search for new parasitic therapies, we have utilized this finding to investigate whether aziridinyl nitrobenzamide derivatives have activity against bloodstream-form Trypanosoma brucei and Trypanosoma cruzi amastigotes, parasite stages that replicate in the mammalian host. For T. cruzi drug screening, we generated trypanosomes that expressed the luciferase reporter gene and optimized a mammalian infection model in a 96-well plate format. A subset of compounds having a 5-(aziridin-1-yl)-2,4-dinitrobenzyl structure was shown to be metabolized by purified T. brucei NTR and when screened against both parasite life cycle stages displayed significant growth-inhibitory properties: the most potent compounds generated 50% inhibitory concentrations of <1 μM. The trypanocidal activity was shown to be NTR specific, since parasites overexpressing this enzyme were hypersensitive to the aziridinyl dinitrobenzyl agents. We conclude that members of the aziridinyl nitrobenzamide class of nitroheterocycles provide new lead structures that have the potential to treat trypanosomal infections.
Insights
New aziridinyl nitrobenzamide derivatives show potent activity against trypanosomal infections. These compounds are activated by nitroreductase (NTR), offering a promising new strategy for treating parasitic diseases.
Area of Science:
- Parasitology
- Medicinal Chemistry
- Drug Discovery
Background:
- Trypanocidal drugs nifurtimox and benznidazole require enzyme activation by nitroreductase (NTR).
- Investigating new therapeutic agents against parasitic infections is crucial.
Purpose of the Study:
- To explore the potential of aziridinyl nitrobenzamide derivatives as trypanocidal agents.
- To assess activity against bloodstream-form Trypanosoma brucei and Trypanosoma cruzi amastigotes.
Main Methods:
- Generated T. cruzi expressing a luciferase reporter gene.
- Optimized a 96-well plate mammalian infection model for drug screening.
- Assessed compound metabolism by purified T. brucei NTR and growth inhibition.
Main Results:
- A subset of 5-(aziridin-1-yl)-2,4-dinitrobenzyl compounds showed significant growth inhibition (<1 μM IC50).
- Compounds were metabolized by T. brucei NTR.
- Parasites overexpressing NTR were hypersensitive, confirming NTR specificity.
Conclusions:
- Aziridinyl nitrobenzamide derivatives are effective against trypanosomal parasites.
- These compounds represent novel lead structures for developing new antiparasitic therapies.
Related Concept Videos
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Antiprotozoal Agents
Anthelminthic Agents
Physical Properties of Amines
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Diazonium Group Substitution: –OH and –H

